Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-12

Clinical Trial Update: Decreasing the Incidence of Delirium After Cardiac Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial aiming to decrease delirium after cardiac surgery has been withdrawn. No further results or actions are planned.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: C.Surgical Procedure; Cardiac, Delirium | Phase 4 | Status: WITHDRAWN